GENE ONLINE|News &
Opinion
Blog

R&D
Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?
2021-08-24
New Study Explores How Sleep Deprivation Inhibits Memory Consolidation
2021-08-07
Kite to Invest in Next Generation Immunotherapy with Appia Bio Collaboration
2021-08-06
Game-Changer in Malaria Prevention: CRISPR-Based Genetic Engineering May Eradicate Malaria Vector Anopheles
2021-08-02
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
Genetics Does Influence the Gut Microbiome, Long Term Research Reveals
2021-07-19
New Gene Therapy Offers Hope to Reverse Rare Genetic Disorder in Children
2021-07-16
Regeneron’s Population Scale Genomic Study Identifies Several Obesity Controlling Genes
2021-07-09
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
FDA Grants Breakthrough Status to Two Experimental Alzheimer’s Drugs While Pushback Over Aduhelm’s Approval Still Rages On
2021-06-25
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
Novartis’ Expensive Gene Therapy for SMA Reasserts its Efficacy in Two Clinical Trials
2021-06-24
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
1 2 3 22
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!